A most stubborn bias: no adjustment method fully resolves confounding by indication in observational studies-Reference-Cited by-同舟云学术

A most stubborn bias: no adjustment method fully resolves confounding by indication in observational studies

Published:2010-01 Issue:1 Volume:63 Page:64-74
ISSN:0895-4356
Container-title:Journal of Clinical Epidemiology
language:en
Short-container-title:Journal of Clinical Epidemiology

Author:

Bosco Jaclyn L.F.,Silliman Rebecca A.,Thwin Soe Soe,Geiger Ann M.,Buist Diana S.M.,Prout Marianne N.,Yood Marianne Ulcickas,Haque Reina,Wei Feifei,Lash Timothy L.

Publisher

Elsevier BV

Subject

Epidemiology

Reference39 articles.

1. Limits of observational data in determining outcomes from cancer therapy;Giordano;Cancer,2008

2. The continuing unethical use of placebo controls;Rothman;N Engl J Med,1994

3. Beyond randomized controlled trials: A critical comparison of trials with nonrandomized studies;Sørensen;Hepatology,2006

4. In defense of pharmacoepidemiology - embracing the yin and yang of drug research;Avorn;N Engl J Med,2007

5. Relation between prepublication release of clinical trial results and the practice of carotid endarterectomy;Gross;JAMA,2000

Cited by 305 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical risk stratification: Development and validation of the DAAE score, a tool for estimating patient risk of transition to secondary progressive multiple sclerosis;Multiple Sclerosis and Related Disorders;2024-09

2. Survival and patient-reported outcomes of real-world high-risk stage II and stage III colon cancer patients after reduction of adjuvant CAPOX duration from 6 to 3 months;European Journal of Cancer;2024-09

3. Toward Precision in Critical Care Research: Methods for Observational and Interventional Studies;Critical Care Medicine;2024-08-15

4. The Population-level Effect of Adjuvant Therapies on Breast Cancer Recurrence: Application of the Trend-in-Trend Design;Epidemiology;2024-08-06

5. Tumor-Infiltrating Lymphocytes in Patients With Stage I Triple-Negative Breast Cancer Untreated With Chemotherapy;JAMA Oncology;2024-08-01